US 6277368
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
expired A61KA61K2039/5152A61K2039/55522
Quick answer
US patent 6277368 (Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine) held by The Regents of the University of California expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/5152, A61K2039/55522, A61K2039/55527, A61K2039/55533